Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centella asiatica leaf extract is a botanical extract derived from the leaves of the Centella asiatica plant, commonly known as Gotu Kola, Tiger Grass, or Cica. It is widely used in cosmetic, dermatological, and phytotherapeutic applications due to its rich content of biologically active pentacyclic triterpenoid saponins, collectively known as centellosides (including asiaticoside, madecassoside, asiatic acid, and madecassic acid). These active compounds stimulate glycosaminoglycan synthesis, promote collagen expression, and exhibit potent anti-inflammatory, antioxidant, and wound-healing properties. While primarily utilized topically in skincare formulations for wound healing, anti-aging, and soothing inflammation, it has also been investigated for potential antibacterial activity and cognitive enhancement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on centella asiatica leaf extract.